Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
284 result(s)
Ellipta inhaler products | GSKpro
27-11-2015
Ellipta inhaler information for UK healthcare professionals including getting started, how to use the Ellipta inhaler and top tips for your patients.
GSKpro for UK healthcare professionals
A portal for UK healthcare professionals containing GSK product information, patient resources, exclusive webinars and more
Ordering and delivery
Find out how to set up an account and start ordering GSK vaccines.
Head-to-head data | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) head-to-head data to support UK healthcare professionals
Guidelines | Anoro▼ Ellipta (umeclidinium / vilanterol)
COPD guidelines information relevant to Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals
vs. LAMA | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA head-to-head data to support UK healthcare professionals
vs. LAMA/LABA | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA/LABA head-to-head data to support UK healthcare professionals
Anoro Patient | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) patient profile information intended to support UK healthcare professionals
Molecules | Anoro▼ Ellipta (umeclidinium / vilanterol)
Information about the molecules in Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals
Webinars & events | GSKpro
A collection of promotional events and webinars featuring experts for UK healthcare professionals
Efficacy
Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.
Home | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Scientific Rationale | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Respiratory
Overview of COPD and severe asthma.
ZEJULA▼
niraparib<br>Oncology
DECTOVA▼
zanamivir IV</br> Influenza
XEVUDY ▼ (sotrovimab)
XEVUDY▼ (sotrovimab) label information for patients and healthcare professionals in Great Britain, including summary of product characteristics and patient information leaflet.
Optimising the Paediatric Severe Asthma Journey Webinar Recording
Optimising the Paediatric Severe Asthma Journey Webinar Recording
Therapy areas | GSKpro UK
Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.
Therapy areas | GSKpro UK
Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.
Video Testimonials: I've Seen Meningitis
Video testimonials from healthcare professionals about the impact of meningitis
XEVUDY ▼ (for GB HCPs)
sotrovimab <br>COVID-19 therapeutics
Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Real world evidence | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Invasive Meningococcal Disease I Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Vaccinate with SHINGRIX | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Sustainability | GSKpro
Information for UK healthcare professionals on GSK’s carbon neutral inhaler and strategy.
Oncology | GSKpro
Oncology at GSK covers a range of therapy areas including ovarian cancer and multiple myeloma. Explore the Oncology GSK resources available to support your appropriate cancer patients.
Quality of life in PRIMA | ZEJULA ▼ (niraparib)
Quality of life data about ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Patient stories | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) patient stories intended to support UK healthcare professionals
BLENREP▼
belantamab mafodotin<br> Oncology
Safety | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Patient Profiles | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Report a possible side effect | GSKpro
Information for UK healthcare professionals on how to report an adverse event related to a GSK product
Contact | GSKpro UK
GSK UK contact page for healthcare professionals.
Dosing & Device | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) dosing & device information to support UK healthcare professionals
Safety | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals
Cost | Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals
Coming soon | GSKpro
This page is under construction. If you require assistance, please connect with our Customer Support team via live chat or request to be contacted by a suitable GSK contact.
Request a contact
Contact us form for UK healthcare professionals to contact GSK
Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
PHN-Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
FAQ | Supply | GSKpro
Frequently asked questions around the supply and availability of GSK medicines and vaccines.
Safety in PRIMA | ZEJULA ▼ (niraparib)
The safety profile and adverse events of ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Resources | ZEJULA ▼ (niraparib)
Resources for UK healthcare professionals | This website contains promotional information about ZEJULA ▼ (niraparib) and is for UK healthcare professionals only.
Efficacy in the PRIMA trial | ZEJULA ▼ (niraparib)
The efficacy data for ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Mechanism of action | ZEJULA ▼ (niraparib)
Overview of the mechanism of action for ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Dosing in PRIMA | ZEJULA ▼ (niraparib)
Recommended dosing for ZEJULA ▼ (niraparib) and dosing in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Patient support for healthcare professionals | ZEJULA ▼ (niraparib)
Resources for healthcare professionals to support patients who have been prescribed ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
ZEJULA ▼ (niraparib)
Overview of ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only
Dosing and administration | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Medicines management and optimisation
For UK healthcare professionals Access bespoke financial and prescribing data for your health economy. Identify variability, track and optimise your implementation projects
Lung Function | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Resources | Nucala (mepolizumab)
For UK Healthcare Professionals - view resources to support you and your patients using Nucala (mepolizumab).
Safety | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)
Bexsero prescribing information for UK healthcare professionals
Expert Perspectives | Nucala (mepolizumab)
For UK Healthcare Professionals - see what the experts have to say about Nucala (mepolizumab).
Nucala (mepolizumab)
Nucala (mepolizumab) information to support UK healthcare professionals.
Exacerbations| Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Safety Information | Nucala (mepolizumab)
See the safety profile of Nucala (mepolizumab) to support UK Healthcare Professionals.
Nucala (mepolizumab)
See the safety profile and efficacy data for Nucala (mepolizumab) to support UK Healthcare Professionals.
Patient support | JEMPERLI ▼ (dostarlimab) UK
Downloadable resources to support patients prescribed Jemperli | This website contains promotional information about JEMPERLI and is for UK healthcare professionals only
JEMPERLI ▼ (dostarlimab) UK
Introducing JEMPERLI ▼ (dostarlimab) | This website contains promotional information about JEMPERLI and is for UK healthcare professionals only
HCP Resources | JEMPERLI ▼ (dostarlimab) UK
Description Video content from ASCO 2022 and downloadable resources for healthcare professionals| This website contains promotional information about JEMPERLI and is for UK healthcare professionals only
JEMPERLI ▼
dostarlimab<br>Oncology
VENTOLIN
salbutamol<br>Respiratory
Experts’ perspectives | Anoro▼ Ellipta (umeclidinium / vilanterol)
Experts' perspectives and patient case study videos relevant to the LAMA/LABA class to support UK healthcare professionals
Dosing & Administration | Nucala (mepolizumab)
Read more about the dosing and administration of Nucala (mepolizumab) to support UK Healthcare Professionals.
Exacerbation Data | Nucala (mepolizumab)
See the exacerbation data for Nucala (mepolizumab) to support UK Healthcare Professionals.
OCS Data | Nucala (mepolizumab)
See the OCS data for Nucala (mepolizumab) to support UK Healthcare Professionals.
Efficacy | Nucala (mepolizumab)
See the efficacy data for Nucala (mepolizumab) to support UK Healthcare Professionals.
Products | GSKpro
GSK product information for UK healthcare professionals
BLENREP▼ (belantamab mafodotin)
BLENREP▼ (belantamab mafodotin) product information for healthcare professionals detailing the efficacy, safety and dosing data
FLIXOTIDE
fluticasone propionate<br>Respiratory
Identifying Patients | Nucala (mepolizumab)
Identify which patients are suitable for treatment with Nucala (mepolizumab) to support UK Healthcare Professionals.
Ventolin (salbutamol) Accuhaler I Flixotide (fluticasone propionate) Accuhaler and Ventolin (salbutamol) Accuhaler
Ventolin (salbutamol) Accuhaler information to support UK healthcare professionals
Home I Flixotide (fluticasone propionate) Accuhaler and Ventolin (salbutamol) Accuhaler
Flixotide (fluticasone propionate) Accuhaler and Ventolin (salbutamol) Accuhaler information to support UK healthcare professionals
Carbon footprints I Flixotide (fluticasone propionate) Accuhaler and Ventolin (salbutamol) Accuhaler
Inhaler carbon footprint information to support UK healthcare professionals
Flixotide (fluticasone propionate) Accuhaler
Flixotide (fluticasone propionate) Accuhaler information to support UK healthcare professionals
HCP resources | ZEJULA ▼ (niraparib)
Expert lead video content, congress highlights and downloadable resources for healthcare professionals | This website contains promotional information about ZEJULA ▼ (niraparib) and is for UK healthcare professionals only
Identifying Patients | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Dose & Device | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) dosing and device information to support UK Healthcare Professionals
Ellipta critical error studies in COPD
Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients
Molecules | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Guidelines | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Home | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Cost | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) price information to support UK Healthcare Professionals
Vaccines
GSK UK information about our vaccines and disease awareness campaigns
HRQoL| Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Patient Profiles | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)
SHINGRIX prescribing information for UK healthcare professionals
Shingles Hear from the Experts
shingles hear from the experts, scientific rationale information for UK healthcare professionals
COPD Resources preview | Respiratory | GSKpro
A preview of educational content for UK healthcare professionals on treating COPD and other respiratory diseases.
Discontinued products | GSK Pro
Discontinued products
Anoro▼ Ellipta (umeclidinium / vilanterol)
Anoro▼ Ellipta (umeclidinium / vilanterol) information to support UK healthcare professionals
Resources | GSKpro
Support your patients and practice with these healthcare resources, ranging from training devices to patient support information.
Safety Information | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals
Supply
Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability
Real Word Evidence | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) data from real world evidence studies to support UK Healthcare Professionals
Shingles real patient stories
shingles real patient story information for UK healthcare professionals
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Show more
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
